kidney disease: improving global outcomes kdigo · • kdigo’s core mission = development,...
TRANSCRIPT
![Page 1: Kidney Disease: Improving Global Outcomes KDIGO · • KDIGO’s core mission = Development, dissemination and implementation of Guidelines • Guideline Updates • Evidence based](https://reader034.vdocuments.mx/reader034/viewer/2022051916/60088c9a505f567c1a4526ad/html5/thumbnails/1.jpg)
Kidney Disease: Improving Global Outcomes
KDIGOWHAT IS IT AND WHY IS IT IMPORTANT?
Professor Michel JadoulCliniques universitaires Saint-LucUniversité catholique de Louvain
Brussels, Belgium
![Page 2: Kidney Disease: Improving Global Outcomes KDIGO · • KDIGO’s core mission = Development, dissemination and implementation of Guidelines • Guideline Updates • Evidence based](https://reader034.vdocuments.mx/reader034/viewer/2022051916/60088c9a505f567c1a4526ad/html5/thumbnails/2.jpg)
DISCLOSURES
Research Support: Amgen, Janssen‐Cilag, MSD, Otsuka, Roche
Lecturing: Abbvie, Amgen, Menarini, MSD, Vifor‐FMCRP
Consulting activities: Astellas, Vifor‐FMCRP, MSD
Travel support: Sanofi‐Genzyme
Other : I have cochaired the 2018 update of the HCV in CKD KDIGO Guideline and am cochair of KDIGO
![Page 3: Kidney Disease: Improving Global Outcomes KDIGO · • KDIGO’s core mission = Development, dissemination and implementation of Guidelines • Guideline Updates • Evidence based](https://reader034.vdocuments.mx/reader034/viewer/2022051916/60088c9a505f567c1a4526ad/html5/thumbnails/3.jpg)
GLOBAL SCIENCELOCAL CHANGE
Kidney Disease: Improving Global Outcomes
![Page 4: Kidney Disease: Improving Global Outcomes KDIGO · • KDIGO’s core mission = Development, dissemination and implementation of Guidelines • Guideline Updates • Evidence based](https://reader034.vdocuments.mx/reader034/viewer/2022051916/60088c9a505f567c1a4526ad/html5/thumbnails/4.jpg)
• Clinical Practice Guidelines in Nephrology began in 1995 Under the umbrella of the US National Kidney Foundation (NKF) DOQI – K/DOQI - Produced guidelines through 2002
• Concept of Global Clinical Practice Guidelines explored in 2003 & 2004Concept included forming a new global organizationKDIGO launched in 2004Incorporated in Belgium as a non-profit foundationContinued to be managed by NKF under a service contract
• KDIGO grew through 2012 when it became independentKDIGO became self governed and self financedLed by active volunteers and a small staffOver 1,000 clinicians and scientists have participated
• KDIGO is funded by many sources, is transparent and financially stableNo funding directly from industry for guidelines or guideline updatesFunding is sought for general support, conferences, and implementation activities
KDIGO HISTORY
Garabed Eknoyan, M.D.
![Page 5: Kidney Disease: Improving Global Outcomes KDIGO · • KDIGO’s core mission = Development, dissemination and implementation of Guidelines • Guideline Updates • Evidence based](https://reader034.vdocuments.mx/reader034/viewer/2022051916/60088c9a505f567c1a4526ad/html5/thumbnails/5.jpg)
KDIGO MISSION
Improving the care and outcomes of patients with kidney disease worldwide through the development and implementation of global
clinical practice guidelines.
![Page 6: Kidney Disease: Improving Global Outcomes KDIGO · • KDIGO’s core mission = Development, dissemination and implementation of Guidelines • Guideline Updates • Evidence based](https://reader034.vdocuments.mx/reader034/viewer/2022051916/60088c9a505f567c1a4526ad/html5/thumbnails/6.jpg)
2019 KDIGO LEADERSHIP
Michel Jadoul, Belgium Wolfgang Winkelmayer, USA
Mustafa Arici, TurkeyTara Chang, USA
John Davis, CEO, USAJohn Gill, Canada
Morgan Grams, USAFan Fan Hou, ChinaKunitoshi Iseki, Japan
Magdalena Madero, MexicoJolanta Malyszko, Poland
Ikechi Okpechi, South AfricaRukshana Shroff, UKLaura Sola, Uruguay
Paul Stevens, Secretary‐Treasurer, UKMarcello Tonelli, Methods Chair, Canada
Suzanne Watnick, USAAngela Webster, Australia
David Wheeler, UKChristina Wyatt, USA
Executive Committee Members:
KDIGO Co‐Chairs:
![Page 7: Kidney Disease: Improving Global Outcomes KDIGO · • KDIGO’s core mission = Development, dissemination and implementation of Guidelines • Guideline Updates • Evidence based](https://reader034.vdocuments.mx/reader034/viewer/2022051916/60088c9a505f567c1a4526ad/html5/thumbnails/7.jpg)
2019 KDIGO LEADERSHIP
Michel Jadoul, Belgium Wolfgang Winkelmayer, USA
Mustafa Arici, TurkeyTara Chang, USA
John Davis, CEO, USAJohn Gill, Canada
Morgan Grams, USAFan Fan Hou, ChinaKunitoshi Iseki, Japan
Magdalena Madero, MexicoJolanta Malyszko, Poland
Ikechi Okpechi, South AfricaRukshana Shroff, UKLaura Sola, Uruguay
Paul Stevens, Secretary‐Treasurer, UKMarcello Tonelli, Methods Chair, Canada
Suzanne Watnick, USAAngela Webster, Australia
David Wheeler, UKChristina Wyatt, USA
Executive Committee Members:
KDIGO Co‐Chairs:
![Page 8: Kidney Disease: Improving Global Outcomes KDIGO · • KDIGO’s core mission = Development, dissemination and implementation of Guidelines • Guideline Updates • Evidence based](https://reader034.vdocuments.mx/reader034/viewer/2022051916/60088c9a505f567c1a4526ad/html5/thumbnails/8.jpg)
• Translate scientific advances into useful clinical practice recommendations and observations.
• Continuously improve its brand representing trusted and usable global scientific information.
• Make the global science available and understandable to clinicians around the world.
• Implement its work through local and regional programs taking into account cultural, economic, language, regulatory and environmental issues.
• Adapt, simplify, prioritize and validate recommendations and observations for clinicians’ use in everyday practice.
KDIGO AIMS TO
![Page 9: Kidney Disease: Improving Global Outcomes KDIGO · • KDIGO’s core mission = Development, dissemination and implementation of Guidelines • Guideline Updates • Evidence based](https://reader034.vdocuments.mx/reader034/viewer/2022051916/60088c9a505f567c1a4526ad/html5/thumbnails/9.jpg)
KDIGO’s AGENDA• Clinical Practice Guidelines
• KDIGO’s core mission = Development, dissemination and implementation of Guidelines
• Guideline Updates• Evidence based
• Controversies Conferences• Conferences that examine significant topics in nephrology and related disciplines that are not fully
resolved. Over 40 so far. Each results in a published Conference Report, usually in Kidney International. Often a Controversies Conference will prompt development of a guideline.
• Implementation Summits• Gathers KOL’s from a country or region to discuss barriers and opportunities for implementation of
KDIGO recommendations
• Implementation Conferences or sessions• Usually through invitations from regional or national nephrology societies
• Educational Tools• Variety of formats, languages, electronic or print, resource driven
![Page 10: Kidney Disease: Improving Global Outcomes KDIGO · • KDIGO’s core mission = Development, dissemination and implementation of Guidelines • Guideline Updates • Evidence based](https://reader034.vdocuments.mx/reader034/viewer/2022051916/60088c9a505f567c1a4526ad/html5/thumbnails/10.jpg)
KDIGO Clinical Practice Guidelines
![Page 11: Kidney Disease: Improving Global Outcomes KDIGO · • KDIGO’s core mission = Development, dissemination and implementation of Guidelines • Guideline Updates • Evidence based](https://reader034.vdocuments.mx/reader034/viewer/2022051916/60088c9a505f567c1a4526ad/html5/thumbnails/11.jpg)
Lipid Management November 2013CKD-MBD Update July 2017
Living Kidney Donors August 2017Hepatitis C Update October 2018
KDIGO GUIDELINES
Hepatitis C April 2008Mineral Bone Disorder July 2009Transplant Recipient Oct 2009
Acute Kidney Injury March 2012
Glomerulonephritis June 2012Anemia August 2012
Blood Pressure in CKD November 2012Diagnosis and Management of CKD January 2013
![Page 12: Kidney Disease: Improving Global Outcomes KDIGO · • KDIGO’s core mission = Development, dissemination and implementation of Guidelines • Guideline Updates • Evidence based](https://reader034.vdocuments.mx/reader034/viewer/2022051916/60088c9a505f567c1a4526ad/html5/thumbnails/12.jpg)
KDIGO ACTIVITIES • Controversies Conferences
• CKD – CVD Series
• Arrhythmias - 2016
• Heart Failure - 2017
• Coronary Artery Disease - 2018
• Non-Cardiac CVD, Stroke - 2020
• Potassium Management - 2018
• Anemia Series - #1 Dec 2019; #2 Q3 2020
• Dialysis Series
• Dialysis Initiation - 2018
• Blood Pressure and Dialysis - 2019
• Home Dialysis - Q2 2020
• Symptom-Based Complications in Dialysis - 2020
• Acute Kidney Injury - 2019
• Early Identification & Intervention - 2019
• Clinical Practice Guidelines
• Bone and Mineral Metabolism Update - 2017
• Hepatitis C and CKD (“Update”) - 2018
• Transplant Candidate Selection - 2019
• Blood Pressure and CKD Update - Currently Under Development
• Glomerular Diseases Update - Currently Under Development
• Diabetes Guideline - Currently Under Development
![Page 13: Kidney Disease: Improving Global Outcomes KDIGO · • KDIGO’s core mission = Development, dissemination and implementation of Guidelines • Guideline Updates • Evidence based](https://reader034.vdocuments.mx/reader034/viewer/2022051916/60088c9a505f567c1a4526ad/html5/thumbnails/13.jpg)
KDIGO ImplementationActivities
Examples from the 2017 CKD‐MBD Guideline Update
![Page 14: Kidney Disease: Improving Global Outcomes KDIGO · • KDIGO’s core mission = Development, dissemination and implementation of Guidelines • Guideline Updates • Evidence based](https://reader034.vdocuments.mx/reader034/viewer/2022051916/60088c9a505f567c1a4526ad/html5/thumbnails/14.jpg)
CKD‐MBD UPDATE ‐ PRESS & COMMENTARIES
![Page 15: Kidney Disease: Improving Global Outcomes KDIGO · • KDIGO’s core mission = Development, dissemination and implementation of Guidelines • Guideline Updates • Evidence based](https://reader034.vdocuments.mx/reader034/viewer/2022051916/60088c9a505f567c1a4526ad/html5/thumbnails/15.jpg)
CKD‐MBD GUIDELINEUPDATE: IMPLEMENTATION TOOLS
http://kdigo.org/guidelines/ckd-mbd/
• CKD‐MBD Quick Reference Guide
![Page 16: Kidney Disease: Improving Global Outcomes KDIGO · • KDIGO’s core mission = Development, dissemination and implementation of Guidelines • Guideline Updates • Evidence based](https://reader034.vdocuments.mx/reader034/viewer/2022051916/60088c9a505f567c1a4526ad/html5/thumbnails/16.jpg)
CKD‐MBD GUIDELINEUPDATE: IMPLEMENTATION TOOLS
http://kdigo.org/guidelines/ckd-mbd/
• Summary of 2017 CKD‐MBD Guideline Update Recommendations
• 2017 CKD‐MBD Guideline Update Speaker’s Guide
![Page 17: Kidney Disease: Improving Global Outcomes KDIGO · • KDIGO’s core mission = Development, dissemination and implementation of Guidelines • Guideline Updates • Evidence based](https://reader034.vdocuments.mx/reader034/viewer/2022051916/60088c9a505f567c1a4526ad/html5/thumbnails/17.jpg)
KDIGO‐ISN WEBINAR
• 73% Attentiveness
• 125 Attendees
• 77 Interest Rating
• 604 people registered for this webinar – a very high number, if not a record!
• Summarized 3 years of work in 30 minutes
• 20+ Q&A questions in 15 minutes
• Held June 21, 2017
• Recording available at https://academy.theisn.org
![Page 18: Kidney Disease: Improving Global Outcomes KDIGO · • KDIGO’s core mission = Development, dissemination and implementation of Guidelines • Guideline Updates • Evidence based](https://reader034.vdocuments.mx/reader034/viewer/2022051916/60088c9a505f567c1a4526ad/html5/thumbnails/18.jpg)
KDIGO CLINICAL PRACTICE GUIDELINES APP
![Page 19: Kidney Disease: Improving Global Outcomes KDIGO · • KDIGO’s core mission = Development, dissemination and implementation of Guidelines • Guideline Updates • Evidence based](https://reader034.vdocuments.mx/reader034/viewer/2022051916/60088c9a505f567c1a4526ad/html5/thumbnails/19.jpg)
KDIGO Impact
![Page 20: Kidney Disease: Improving Global Outcomes KDIGO · • KDIGO’s core mission = Development, dissemination and implementation of Guidelines • Guideline Updates • Evidence based](https://reader034.vdocuments.mx/reader034/viewer/2022051916/60088c9a505f567c1a4526ad/html5/thumbnails/20.jpg)
KDIGO GUIDELINES – MOST CITED IN KI SUPPLEMENTS
KDIGO Guidelines are the TOP FIVE MOST CITED ARTICLES in Kidney International Supplements
![Page 21: Kidney Disease: Improving Global Outcomes KDIGO · • KDIGO’s core mission = Development, dissemination and implementation of Guidelines • Guideline Updates • Evidence based](https://reader034.vdocuments.mx/reader034/viewer/2022051916/60088c9a505f567c1a4526ad/html5/thumbnails/21.jpg)
The KDIGO conference report on “The definition, classification and prognosis of CKD” is the MOST CITED ARTICLE in Kidney International (658 times)
The 2017 KDIGO conference report on “Screening, diagnosis, and management of patients with Fabry disease” is the FOURTH MOST READ ARTICLE in Kidney International
KDIGO CONFERENCE REPORTS ‐ MOST CITED & MOST READ IN KI
![Page 22: Kidney Disease: Improving Global Outcomes KDIGO · • KDIGO’s core mission = Development, dissemination and implementation of Guidelines • Guideline Updates • Evidence based](https://reader034.vdocuments.mx/reader034/viewer/2022051916/60088c9a505f567c1a4526ad/html5/thumbnails/22.jpg)
KDIGO cited in more than 150 textbooks, not just in nephrology
![Page 23: Kidney Disease: Improving Global Outcomes KDIGO · • KDIGO’s core mission = Development, dissemination and implementation of Guidelines • Guideline Updates • Evidence based](https://reader034.vdocuments.mx/reader034/viewer/2022051916/60088c9a505f567c1a4526ad/html5/thumbnails/23.jpg)
KDIGO IMPACT
![Page 24: Kidney Disease: Improving Global Outcomes KDIGO · • KDIGO’s core mission = Development, dissemination and implementation of Guidelines • Guideline Updates • Evidence based](https://reader034.vdocuments.mx/reader034/viewer/2022051916/60088c9a505f567c1a4526ad/html5/thumbnails/24.jpg)
WHAT LIES AHEAD – CHALLENGES & FORWARD VISION• Expand KDIGO’s Guideline portfolio
• Guideline updates near real time
• Drive cutting edge in guideline methodology
• Expand outreach beyond nephrology
• Further increase diversity in all KDIGO Activities
• Better document KDIGO’s impact on populations